Pharmacokinetic and dose finding study of osimertinib in patients with impaired renal function and low body weight
Not Applicable
Recruiting
- Conditions
- SCLC with EGFR mutation
- Registration Number
- JPRN-UMIN000033301
- Lead Sponsor
- ational Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 36
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with severe concomitant disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method